Specialty Pharmacy

Children exposed to rheumatoid arthritis in utero saw elevated early and late childhood epilepsy risk.

Amgen's request for a permanent injunction granted to prohibit Sanofi/Regeneron from manufacturing and selling PCSK9 inhibitor.

Top news of the week in oncology and cancer drug development.

CanChew Plus CBD Gum to be tested in irritable bowel syndrome clinical trial.

Nonsteroidal anti-inflammatory drugs effective in preventing advanced neoplasia recurrence.

Antenatal ART significantly lowered early mother-to-child HIV transmission rates.

Combination therapy may help combat treatment resistance in cancer patients.

Genentech’s Lucentis granted fifth FDA approval.

Top articles of the week from Specialty Pharmacy Times.

The FDA approved the lowest amount of new drugs since 2010 last year, with only 22 new drugs receiving approval.

HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.

ASN003 demonstrated potent action against tumor growth.

The Aptima HIV-1 Quant assay will significantly cut lab times.

Group-based acceptance and commitment therapy increased likelihood of effective coping strategies in diabetes patients.

Device helps surgeons distinguish between cancerous and non-cancerous tissues.

Combination treatment methods to cure HIV may have harmful side effects.

Top news of the day from across the health care landscape.

Tracking a particular anti-tumor necrosis factor (TNF) through the body can help determine an effective RA dose.

Visionary health care executives selected to take helm of NASP.

Abbreviated new drug applications were accepted for 3 topical generic products on December 30, 2016.

Certain protease inhibitors linked to cognitive issues.

Resetting the Gut Microbiome Offers Potential Treatment for Rare Autoimmune Disease

Aspirin may serve as a preventive measure for pancreatic cancer development.

Certain hypertension drugs block breast and pancreatic cancer invasion.

Top news of the day from across the health care landscape.

Cancer accounts for more years of life lost than any other cause of death.

HIV resistance may necessitate more costly therapies for third-line treatment.

Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.